One of the most bothersome things about being sick or having seasonal allergies is that it makes your nose stuffy and blocked. This makes breathing in through your nostrils frustrating – if not ...
Constantly congested? The culprit could be nasal polyps, noncancerous growths that leave your nose stuffed and your sense of smell stymied. We asked a top ear, nose and throat specialist to tell us ...
This guidance updates and replaces NICE technology appraisal guidance on dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal; TA648). Next review: This guidance will ...
Researchers conducted an indirect treatment comparison (Bucher method) using placebo as a common comparator to evaluate the efficacy of dupilumab and tezepelumab in patients with CRSwNP. The analysis ...
Please provide your email address to receive an email when new articles are posted on . The analysis compared results from the WAYPOINT, SINUS-52 and SYNAPSE studies. Tezepelumab outperformed ...
Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...
Tezepelumab-ekko is now approved for chronic rhinosinusitis with nasal polyps (CRSwNP), targeting thymic stromal lymphopoietin and marking its second indication after severe asthma. The phase 3 ...
Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
Approval broadens indication for TEZSPIRE to a second disease characterized by epithelial-driven inflammation WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (AZN) and Amgen’s TEZSPIRE® (tezepelumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results